Status:
COMPLETED
Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft
Lead Sponsor:
Oregon Health and Science University
Conditions:
Dysphagia
Aspiration
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE4
Brief Summary
Type I laryngeal cleft evaluation and treatment in the pediatric population is an emerging science. The largest published series of pediatric patients with type I laryngeal clefts shows conflicting ev...
Detailed Description
Dysphagia with aspiration is a common disorder in the pediatric population. Aspiration with feeds is diagnosed on modified barium swallow studies and patients are referred to the pediatric otolaryngol...
Eligibility Criteria
Inclusion
- chief complaint of dysphagia and/or aspiration detected on a clinical swallow assessment and/or modified barium swallow study
- able to withstand general anesthesia and direct microlaryngoscopy in the operating room
Exclusion
- inability or parent refusal to undergo procedure under general anesthesia in the operating room
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01507207
Start Date
January 1 2012
End Date
May 15 2015
Last Update
September 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University - Doernbecher Children's Hospital
Portland, Oregon, United States, 97239